U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670702) titled 'An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD' on June 19.
Brief Summary: This study is evaluating the long-term safety and efficacy of TSND-201 in adults with PTSD. Participants that have completed a double-blind clinical trial with TNSD-201 for PTSD will be invited to participate in this open-label extension trial.
Each participant will be able to receive up to three Treatment Courses over the duration of the study (up to 48 weeks). Each Treatment Course includes 4 dosing sessions, spaced one week apart.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Post Traumati...